{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T09:42:21Z","timestamp":1786268541459,"version":"build-2736575974"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100010324","name":"Secretar\u00eda General de Ciencia y T\u00e9cnica, Universidad Nacional del Nordeste","doi-asserted-by":"publisher","award":["PI:21V001"],"award-info":[{"award-number":["PI:21V001"]}],"id":[{"id":"10.13039\/501100010324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010324","name":"Secretar\u00eda General de Ciencia y T\u00e9cnica, Universidad Nacional del Nordeste","doi-asserted-by":"publisher","award":["PI:21F019"],"award-info":[{"award-number":["PI:21F019"]}],"id":[{"id":"10.13039\/501100010324","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00204-026-04450-8","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T09:35:33Z","timestamp":1779269733000},"page":"4275-4290","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CpG-ODN\/Coa-ASC16 nanostructured adjuvant platform as a safe and effective alternative in Bothrops diporus antivenom production"],"prefix":"10.1007","volume":"100","author":[{"given":"Gisela L.","family":"Lopez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline R. C.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos H.","family":"Toyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Maslovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Mor\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura C.","family":"Leiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belkys A.","family":"Maletto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano S.","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"4450_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetpar.2025.110654","author":"M Ahumada","year":"2025","unstructured":"Ahumada M, Guasconi L, Maletto BA et al (2025) Fasciola hepatica vaccine based on Kunitz-type molecule reduces adult worm fecundity in experimentally infected sheep. Vet Parasitol. https:\/\/doi.org\/10.1016\/j.vetpar.2025.110654","journal-title":"Vet Parasitol"},{"key":"4450_CR2","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1023\/A:1007152303179","volume":"38","author":"DG Beghini","year":"2000","unstructured":"Beghini DG, Toyama MH, Hyslop S et al (2000) Enzymatic characterization of a novel phospholipase A2 from Crotalus durissus cascavella rattlesnake (maracamb\u00f3ia) venom. Toxicon 38:759\u2013771. https:\/\/doi.org\/10.1023\/A:1007152303179","journal-title":"Toxicon"},{"key":"4450_CR3","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.70.6.849","author":"A Billiau","year":"2001","unstructured":"Billiau A, Matthys P (2001) Modes of action of Freund\u2019s adjuvants in experimental models of autoimmune diseases. J Leukoc Biol. https:\/\/doi.org\/10.1189\/jlb.70.6.849","journal-title":"J Leukoc Biol"},{"key":"4450_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.30972\/vet.2411141","volume":"24","author":"F Bogado","year":"2013","unstructured":"Bogado F, N\u00fa\u00f1ez S, Mussart NB et al (2013) Cambios cl\u00ednicos, hem\u00e1ticos y coagulativos consecuentes al aumento de anticuerpos en equinos productores de suero antiof\u00eddico. Revista Vet 24:3\u20139","journal-title":"Revista Vet"},{"key":"4450_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(76)90527-3","author":"MM Bradford","year":"1976","unstructured":"Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. https:\/\/doi.org\/10.1016\/0003-2697(76)90527-3","journal-title":"Anal Biochem"},{"key":"4450_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.toxicon.2019.07.004","volume":"168","author":"S Bustillo","year":"2019","unstructured":"Bustillo S, Fern\u00e1ndez J, Chaves-Araya S et al (2019) Isolation of two basic phospholipases A2 from Bothrops diporus snake venom: comparative characterization and synergism between Asp49 and Lys49 variants. Toxicon 168:113\u2013121. https:\/\/doi.org\/10.1016\/j.toxicon.2019.07.004","journal-title":"Toxicon"},{"key":"4450_CR7","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.3389\/fimmu.2018.02319","volume":"9","author":"AL Chiodetti","year":"2018","unstructured":"Chiodetti AL, S\u00e1nchez Vallecillo MF, Dolina JS et al (2018) Class-B CpG-ODN formulated with a nanostructure induces type I interferons-dependent and CD4\u2009+\u2009T cell-independent CD8\u2009+\u2009T-cell response against unconjugated protein antigen. Front Immunol 9:2319. https:\/\/doi.org\/10.3389\/fimmu.2018.02319","journal-title":"Front Immunol"},{"key":"4450_CR8","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S0041-0101(97)00160-8","volume":"36","author":"JP Chippaux","year":"1998","unstructured":"Chippaux JP, Goyffon M (1998) Venoms, antivenoms and immunotherapy. Toxicon 36:823\u2013846. https:\/\/doi.org\/10.1016\/S0041-0101(97)00160-8","journal-title":"Toxicon"},{"key":"4450_CR9","volume-title":"InfoStat versi\u00f3n 2015. Grupo InfoStat","author":"JA Di Rienzo","year":"2015","unstructured":"Di Rienzo JA, Casanoves F, Balzarini MG et al (2015) InfoStat versi\u00f3n 2015. Grupo InfoStat. FCA, Universidad Nacional de C\u00f3rdoba, Argentina. https:\/\/www.infostat.com.ar\/"},{"key":"4450_CR10","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/j.jprot.2011.03.026","volume":"74","author":"T Escalante","year":"2011","unstructured":"Escalante T, Rucavado A, Fox JW, Guti\u00e9rrez JM (2011) Key events in microvascular damage induced by snake venom hemorrhagic metalloproteinases. J Proteom 74:1781\u20131794. https:\/\/doi.org\/10.1016\/j.jprot.2011.03.026","journal-title":"J Proteom"},{"key":"4450_CR11","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1189\/jlb.1104631","volume":"78","author":"M Feili-Hariri","year":"2005","unstructured":"Feili-Hariri M, Falkner DH, Morel PA (2005) Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy. J Leukoc Biol 78:656\u2013664. https:\/\/doi.org\/10.1189\/jlb.1104631","journal-title":"J Leukoc Biol"},{"key":"4450_CR12","unstructured":"Freund J (1956) The mode of action of immunologic adjuvants. Bibl Tuberc 130\u2013148"},{"key":"4450_CR13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.toxicon.2022.05.045","volume":"215","author":"LS Fusco","year":"2022","unstructured":"Fusco LS, Pascual MM, Hernandez D et al (2022) CpG-ODN formulated with a nanostructure as adjuvant for anticrotalic serum production. Studies in mice. Toxicon 215:28\u201336. https:\/\/doi.org\/10.1016\/j.toxicon.2022.05.045","journal-title":"Toxicon"},{"key":"4450_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/trstmh\/trae129","author":"LS Fusco","year":"2025","unstructured":"Fusco LS, Lopez GL, Maslovski F et al (2025) Evaluation of a nanostructured CpG-ODN\/ascorbyl palmitate as a safe and effective adjuvant for anticrotalic PLA2 serum. Trans R Soc Trop Med Hyg. https:\/\/doi.org\/10.1093\/trstmh\/trae129","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"4450_CR15","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1586\/14789450.2014.939635","volume":"11","author":"R Ghosh","year":"2014","unstructured":"Ghosh R, Gilda JE, Gomes AV (2014) The necessity of and strategies for improving confidence in the accuracy of western blots. Expert Rev Proteom 11:549\u2013560. https:\/\/doi.org\/10.1586\/14789450.2014.939635","journal-title":"Expert Rev Proteom"},{"key":"4450_CR16","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1016\/j.cell.2025.03.050","volume":"188","author":"J Glanville","year":"2025","unstructured":"Glanville J, Bellin M, Pletnev S et al (2025) Snake venom protection by a cocktail of varespladib and broadly neutralizing human antibodies. Cell 188:3117-3134e11. https:\/\/doi.org\/10.1016\/j.cell.2025.03.050","journal-title":"Cell"},{"key":"4450_CR17","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.toxicon.2005.02.029","volume":"45","author":"JM Guti\u00e9rrez","year":"2005","unstructured":"Guti\u00e9rrez JM, Rucavado A, Escalante T, D\u00edaz C (2005) Hemorrhage induced by snake venom metalloproteinases: biochemical and biophysical mechanisms involved in microvessel damage. Toxicon 45:997\u20131011. https:\/\/doi.org\/10.1016\/j.toxicon.2005.02.029","journal-title":"Toxicon"},{"key":"4450_CR18","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.toxicon.2009.01.039","volume":"54","author":"JM Guti\u00e9rrez","year":"2009","unstructured":"Guti\u00e9rrez JM, Escalante T, Rucavado A (2009) Experimental pathophysiology of systemic alterations induced by Bothrops asper snake venom. Toxicon 54:976\u2013987. https:\/\/doi.org\/10.1016\/j.toxicon.2009.01.039","journal-title":"Toxicon"},{"key":"4450_CR19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.toxicon.2012.11.016","volume":"69","author":"JM Guti\u00e9rrez","year":"2013","unstructured":"Guti\u00e9rrez JM, Solano G, Pla D et al (2013) Assessing the preclinical efficacy of antivenoms: from the lethality neutralization assay to antivenomics. Toxicon 69:168\u2013179. https:\/\/doi.org\/10.1016\/j.toxicon.2012.11.016","journal-title":"Toxicon"},{"key":"4450_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/toxins9050163","author":"JM Guti\u00e9rrez","year":"2017","unstructured":"Guti\u00e9rrez JM, Solano G, Pla D et al (2017) Preclinical evaluation of the efficacy of antivenoms for snakebite envenoming: state-of-the-art and challenges ahead. Toxins (Basel). https:\/\/doi.org\/10.3390\/toxins9050163","journal-title":"Toxins (Basel)"},{"key":"4450_CR21","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1016\/S0264-410X(02)00026-9","volume":"20","author":"RA Harrison","year":"2002","unstructured":"Harrison RA, Richards A, Laing GD, Theakston RDG (2002) Simultaneous GeneGun immunisation with plasmids encoding antigen and GM-CSF: Significant enhancement of murine antivenom IgG1 titres. Vaccine 20:1702\u20131706. https:\/\/doi.org\/10.1016\/S0264-410X(02)00026-9","journal-title":"Vaccine"},{"key":"4450_CR22","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/nrd2059","volume":"5","author":"AM Krieg","year":"2006","unstructured":"Krieg AM (2006) Therapeutic potential of toll-like receptor 9 activation. Nat Rev Drug Discov 5:471\u2013484. https:\/\/doi.org\/10.1038\/nrd2059","journal-title":"Nat Rev Drug Discov"},{"key":"4450_CR23","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1089\/nat.2012.0340","volume":"22","author":"AM Krieg","year":"2012","unstructured":"Krieg AM (2012) CpG still rocks! Update on an accidental drug. Nucleic Acid Ther 22:77\u201389. https:\/\/doi.org\/10.1089\/nat.2012.0340","journal-title":"Nucleic Acid Ther"},{"key":"4450_CR24","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/227680a0","volume":"227","author":"UK Laemmli","year":"1970","unstructured":"Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680\u2013685","journal-title":"Nature"},{"key":"4450_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179643","author":"S Larr\u00e9ch\u00e9","year":"2021","unstructured":"Larr\u00e9ch\u00e9 S, Chippaux JP, Chevillard L et al (2021) Bleeding and thrombosis: insights into pathophysiology of Bothrops venom-related hemostasis disorders. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22179643","journal-title":"Int J Mol Sci"},{"key":"4450_CR26","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1080\/14760584.2021.1908133","volume":"20","author":"GH Lee","year":"2021","unstructured":"Lee GH, Lim SG (2021) CpG-adjuvanted hepatitis B vaccine (HEPLISAV-B\u00ae) update. Expert Rev Vaccines 20:487\u2013495. https:\/\/doi.org\/10.1080\/14760584.2021.1908133","journal-title":"Expert Rev Vaccines"},{"key":"4450_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2023.107351","author":"GL Lopez","year":"2024","unstructured":"Lopez GL, Van de Velde A, Hern\u00e1ndez D et al (2024) Potential low-impact immunogen for the production of anti-bothropic serum: Bothrops alternatus venom treated with Na2EDTA. Toxicon. https:\/\/doi.org\/10.1016\/j.toxicon.2023.107351","journal-title":"Toxicon"},{"key":"4450_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26199496","volume":"26","author":"GL Lopez","year":"2025","unstructured":"Lopez GL, Nielsen SA, Nielsen VG, Fusco LS (2025) Procoagulant effects of Bothrops diporus venom: kinetic modeling and role of serine protease activity. Int J Mol Sci 26:9496. https:\/\/doi.org\/10.3390\/ijms26199496","journal-title":"Int J Mol Sci"},{"key":"4450_CR29","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1152\/ajpcell.00400.2014","volume":"308","author":"AA Mcdonough","year":"2015","unstructured":"Mcdonough AA, Veiras LC, Minas JN, Ralph DL (2015) Considerations when quantitating protein abundance by immunoblot. Am J Physiol Cell Physiol 308:426\u2013433. https:\/\/doi.org\/10.1152\/ajpcell.00400.2014","journal-title":"Am J Physiol Cell Physiol"},{"key":"4450_CR30","doi-asserted-by":"publisher","first-page":"15553","DOI":"10.1073\/pnas.95.26.15553","volume":"95","author":"CLB Millan","year":"1998","unstructured":"Millan CLB, Weeratna R, Krieg AM et al (1998) CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice. Proc Natl Acad Sci U S A 95:15553\u201315558. https:\/\/doi.org\/10.1073\/pnas.95.26.15553","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4450_CR31","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.rvsc.2021.02.011","volume":"135","author":"MC Moran","year":"2021","unstructured":"Moran MC, Bence AR, Vallecillo MFS et al (2021) Polymeric antigen BLSOmp31 formulated with class B CpG-ODN in a nanostructure (BLSOmp31\/CpG-ODN\/Coa-ASC16) administered by parenteral or mucosal routes confers protection against Brucella ovis in Balb\/c mice. Res Vet Sci 135:217\u2013227. https:\/\/doi.org\/10.1016\/j.rvsc.2021.02.011","journal-title":"Res Vet Sci"},{"key":"4450_CR32","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1365-3024.1994.tb00306.x","volume":"16","author":"AP Mountford","year":"1994","unstructured":"Mountford AP, Fisher A, Wilson RA (1994) The profile of IgG1 and IgG2a antibody responses in mice exposed to Schistosoma mansoni. Parasite Immunol 16:521\u2013527. https:\/\/doi.org\/10.1111\/j.1365-3024.1994.tb00306.x","journal-title":"Parasite Immunol"},{"key":"4450_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2024.1428713","volume":"11","author":"H Oboge","year":"2024","unstructured":"Oboge H, Riitho V, Nyamai M et al (2024) Safety and efficacy of toll-like receptor agonists as therapeutic agents and vaccine adjuvants for infectious diseases in animals: a systematic review. Front Vet Sci 11:1428713. https:\/\/doi.org\/10.3389\/fvets.2024.1428713","journal-title":"Front Vet Sci"},{"key":"4450_CR34","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.immuni.2013.10.006","volume":"39","author":"NW Palm","year":"2013","unstructured":"Palm NW, Rosenstein RK, Yu S et al (2013) Bee venom phospholipase A2 induces a primary type 2 response that is dependent on the receptor ST2 and confers protective immunity. Immunity 39:976\u2013985. https:\/\/doi.org\/10.1016\/j.immuni.2013.10.006","journal-title":"Immunity"},{"key":"4450_CR35","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ijpharm.2007.09.014","volume":"345","author":"S Palma","year":"2007","unstructured":"Palma S, Manzo R, Lo Nostro P, Allemandi D (2007) Nanostructures from alkyl vitamin C derivatives (ASCn): properties and potential platform for drug delivery. Int J Pharm 345:26\u201334. https:\/\/doi.org\/10.1016\/j.ijpharm.2007.09.014","journal-title":"Int J Pharm"},{"key":"4450_CR36","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0022-1759(86)90268-1","volume":"86","author":"GR Pullen","year":"1986","unstructured":"Pullen GR, Fitzgerald MG, Hosking CS (1986) Antibody avidity determination by ELISA using thiocyanate elution. J Immunol Methods 86:83\u201387","journal-title":"J Immunol Methods"},{"key":"4450_CR37","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1590\/S1678-91992012000100015","volume":"18","author":"JP Rodr\u00edguez","year":"2012","unstructured":"Rodr\u00edguez JP, Gay CC, Fusco LS et al (2012) Cross-neutralization of the coagulant activity of Crotalus durissus terrificus venom from the northeast of Argentina by bivalent bothropic antivenom. J Venom Anim Toxins Incl Trop Dis 18:116\u2013123. https:\/\/doi.org\/10.1590\/S1678-91992012000100015","journal-title":"J Venom Anim Toxins Incl Trop Dis"},{"key":"4450_CR38","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1055\/s-0037-1615657","volume":"85","author":"A Rucavado","year":"2001","unstructured":"Rucavado A, Soto M, Kamiguti AS et al (2001) Characterization of aspercetin, a platelet aggregating component from the venom of the snake Bothrops asper which induces thrombocytopenia and potentiates metalloproteinase-induced hemorrhage. Thromb Haemost 85:710\u2013715. https:\/\/doi.org\/10.1055\/s-0037-1615657","journal-title":"Thromb Haemost"},{"key":"4450_CR39","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1160\/TH05-02-0112","volume":"94","author":"A Rucavado","year":"2005","unstructured":"Rucavado A, Soto M, Escalante T et al (2005) Thrombocytopenia and platelet hypoaggregation induced by Bothrops asper snake venom. Thromb Haemost 94:123\u2013131. https:\/\/doi.org\/10.1160\/TH05-02-0112","journal-title":"Thromb Haemost"},{"key":"4450_CR40","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1016\/j.biomaterials.2013.12.002","volume":"35","author":"MF S\u00e1nchez Vallecillo","year":"2014","unstructured":"S\u00e1nchez Vallecillo MF, Ullio Gamboa GV, Palma SD et al (2014) Adjuvant activity of CpG-ODN formulated as a liquid crystal. Biomaterials 35:2529\u20132542. https:\/\/doi.org\/10.1016\/j.biomaterials.2013.12.002","journal-title":"Biomaterials"},{"key":"4450_CR41","doi-asserted-by":"publisher","unstructured":"S\u00e1nchez Vallecillo MF, De La Escalera M, Aguirre MMMV et al (2015) A liquid crystal of ascorbyl palmitate, used as vaccine platform, provides sustained release of antigen and has intrinsic pro-inflammatory and adjuvant activities which are dependent on MyD88 adaptor protein. J Control Release 214:12\u201322. https:\/\/doi.org\/10.1016\/j.jconrel.2015.07.008","DOI":"10.1016\/j.jconrel.2015.07.008"},{"key":"4450_CR42","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/0041-0101(87)90286-8","volume":"25","author":"B Sannanaik Vishwanath","year":"1987","unstructured":"Sannanaik Vishwanath B, Icini RM, Erabasappa Gowdat TV (1987) Characterization of three edema-inducing phospholipase A2 enzymes from habu (Trimeresurus flavoviridis) venom and their interaction with the alkaloid aristolochic acid. Toxicon 25:501\u2013515. https:\/\/doi.org\/10.1016\/0041-0101(87)90286-8","journal-title":"Toxicon"},{"key":"4450_CR43","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.toxicon.2010.07.001","volume":"56","author":"A Segura","year":"2010","unstructured":"Segura A, Castillo MC, N\u00fa\u00f1ez V et al (2010) Preclinical assessment of the neutralizing capacity of antivenoms produced in six Latin American countries against medically-relevant Bothrops snake venoms. Toxicon 56:980\u2013989. https:\/\/doi.org\/10.1016\/j.toxicon.2010.07.001","journal-title":"Toxicon"},{"key":"4450_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02087","volume":"11","author":"L Silvane","year":"2020","unstructured":"Silvane L, Celias DP, Romagnoli PA et al (2020) A vaccine based on Kunitz-type molecule confers protection against Fasciola hepatica challenge by inducing IFN-\u03b3 and antibody immune responses through IL-17A production. Front Immunol 11:2087. https:\/\/doi.org\/10.3389\/fimmu.2020.02087","journal-title":"Front Immunol"},{"key":"4450_CR45","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1016\/j.vaccine.2010.08.002","volume":"29","author":"F Steinhagen","year":"2011","unstructured":"Steinhagen F, Kinjo T, Bode C, Klinman DM (2011) TLR-based immune adjuvants. Vaccine 29:3341\u20133355. https:\/\/doi.org\/10.1016\/j.vaccine.2010.08.002","journal-title":"Vaccine"},{"key":"4450_CR46","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/361590","volume":"2014","author":"SC Taylor","year":"2014","unstructured":"Taylor SC, Posch A (2014) The design of a quantitative western blot experiment. Biomed Res Int 2014. https:\/\/doi.org\/10.1155\/2014\/361590","journal-title":"Biomed Res Int"},{"key":"4450_CR47","first-page":"949","volume":"61","author":"RDG Theakston","year":"1983","unstructured":"Theakston RDG, Reid HA (1983) Development of simple standard assay procedures for the characterization of snake venoms. Bull World Health Organ 61:949","journal-title":"Bull World Health Organ"},{"key":"4450_CR48","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0041-0101(02)00393-8","volume":"41","author":"RDG Theakston","year":"2003","unstructured":"Theakston RDG, Warrell DA, Griffiths E (2003) Report of a WHO workshop on the standardization and control of antivenoms. Toxicon 41:541\u2013557. https:\/\/doi.org\/10.1016\/S0041-0101(02)00393-8","journal-title":"Toxicon"},{"key":"4450_CR49","doi-asserted-by":"publisher","first-page":"5654","DOI":"10.4049\/jimmunol.0900645","volume":"183","author":"JT Tigno-Aranjuez","year":"2009","unstructured":"Tigno-Aranjuez JT, Jaini R, Tuohy VK et al (2009) Encephalitogenicity of complete Freund\u2019s adjuvant relative to CpG is linked to induction of Th17 cells. J Immunol 183:5654\u20135566. https:\/\/doi.org\/10.4049\/jimmunol.0900645","journal-title":"J Immunol"},{"key":"4450_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/toxins13120865","volume":"13","author":"LR Tsuruta","year":"2021","unstructured":"Tsuruta LR, Moro AM, Tambourgi DV, Sant\u2019Anna OA (2021) Oral tolerance induction by Bothrops jararaca venom in a murine model and cross-reactivity with toxins of other snake venoms. Toxins (Basel) 13:865. https:\/\/doi.org\/10.3390\/toxins13120865","journal-title":"Toxins (Basel)"},{"key":"4450_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1043109","volume":"14","author":"SK Verma","year":"2023","unstructured":"Verma SK, Mahajan P, Singh NK et al (2023) New-age vaccine adjuvants, their development, and future perspective. Front Immunol 14:1043109. https:\/\/doi.org\/10.3389\/fimmu.2023.1043109","journal-title":"Front Immunol"},{"key":"4450_CR52","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613061","author":"WJ Wang","year":"2002","unstructured":"Wang WJ, Huang TF (2002) Purification and characterization of a novel metalloproteinase, acurhagin, from Agkistrodon acutus venom. Thromb Haemost. https:\/\/doi.org\/10.1055\/s-0037-1613061","journal-title":"Thromb Haemost"},{"key":"4450_CR53","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/0041-0101(96)83654-3","volume":"2","author":"DA Warrell","year":"1996","unstructured":"Warrell DA (1996) Clinical features of envenoming from snakebites. Toxicon 2:144","journal-title":"Toxicon"},{"key":"4450_CR54","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0140-6736(09)61754-2","volume":"375","author":"DA Warrell","year":"2010","unstructured":"Warrell DA (2010) Snake bite. Lancet 375:77\u201388","journal-title":"Lancet"},{"key":"4450_CR55","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/01.shk.0000142249.08135.e9","volume":"22","author":"H Watanabe","year":"2004","unstructured":"Watanabe H, Numata K, Ito T et al (2004) Innate immune response in Th1-and Th2-dominant mouse strains. Shock 22:460\u2013466. https:\/\/doi.org\/10.1097\/01.shk.0000142249.08135.e9","journal-title":"Shock"},{"key":"4450_CR56","unstructured":"World Health Organization (2023) Snakebite envenoming. Fact sheet. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/snakebite-envenoming"},{"key":"4450_CR57","doi-asserted-by":"publisher","DOI":"10.1051\/jbio\/2009043","volume-title":"WHO guidelines for the production, control and regulation of snake antivenom immunoglobulins","author":"World Health Organization","year":"2010","unstructured":"World Health Organization (2010) WHO guidelines for the production, control and regulation of snake antivenom immunoglobulins. World Health Organization, Geneva. https:\/\/doi.org\/10.1051\/jbio\/2009043"},{"key":"4450_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01557-7","volume":"8","author":"T Zhao","year":"2023","unstructured":"Zhao T, Cai Y, Jiang Y et al (2023) Vaccine adjuvants: mechanisms and platforms. Signal Transduct Target Ther 8:283. https:\/\/doi.org\/10.1038\/s41392-023-01557-7","journal-title":"Signal Transduct Target Ther"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-026-04450-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-026-04450-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-026-04450-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T09:31:50Z","timestamp":1786267910000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-026-04450-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":58,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["4450"],"URL":"https:\/\/doi.org\/10.1007\/s00204-026-04450-8","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"1 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}}]}}